Story of the day
Accelerated by the pandemic, healthcare firms have achieved significant progress in developing improved cures and healthcare solutions.
Has #ideas2invest been useful to you?
Please click here to share your feedback.
Click to view graphics
What does this mean for your portfolio?
The Healthcare sector accounts for c.15% of the global equities benchmark, and demonstrates stable and secular growth characteristics alongside a defensive nature. Driven by a wide range of secular factors, we believe the sector’s future remains bright.
Ready to act now?
Simply click on the stock or fund name below for direct access to our online trading platforms.
We like these:
Janus Henderson Global Life Sciences
Active, diversified portfolio of c.100 names across four sub-sectors: Pharmaceuticals, Biotech, Healthcare Services, and Medical Devices & Technology.
Stock selection is categorised into 3 buckets, namely Core Growth, Emerging Growth, and Opportunistic, and spread across sub-sectors, market cap and business models.
The fund is led by portfolio manager Andy Acker, who has been managing the fund since 2007, and is supported by a large team of 7 dedicated analysts trained in both Finance and Healthcare.
Not a DBS client?
Open a trading account with us today.
More insights on the go:
CIO Insights 2Q22: Anchor in the Storm
2-min video
Gold remains a safe haven
2-min video
China: Improving and on track for summer 2023 reopening
5-min article
Asset Allocation: Don't fear the curve inversion
5-min article